# Anika Therapeutics (ANIK) — Analyst Forecast

ANIK · NASDAQ · Stock

Canonical page: https://www.lighthorse.io/tickers/anik/forecast

## Recent analyst ratings

| Date | Firm | Action | Rating | Price target |
| --- | --- | --- | --- | --- |
| Sep 18, 2026 | B. Riley Securities | Initiated Coverage | Buy | $23.00 |
| Jul 30, 2026 | B. Riley Securities | Maintained | Buy | $21.00 |
| Feb 27, 2026 | Barrington Research | Maintained | Outperform | $17.00 |
| Jan 9, 2026 | Barrington Research | Maintained | Outperform | $16.00 |
| Nov 6, 2025 | Barrington Research | Maintained | Outperform | $16.00 |
| Sep 23, 2025 | Barrington Research | Maintained | Outperform | $15.00 |
| Jul 31, 2025 | Barrington Research | Maintained | Outperform | $15.00 |
| May 12, 2025 | Barrington Research | Maintained | Outperform | $19.00 |
| Mar 13, 2025 | Barrington Research | Maintained | Outperform | $20.00 |
| Nov 1, 2024 | Barrington Research | Maintained | Outperform | $25.00 |
| Oct 22, 2024 | Barrington Research | Maintained | Outperform | $37.00 |
| Aug 9, 2024 | Barrington Research | Maintained | Outperform | $37.00 |
| May 29, 2024 | Stephens & Co. | Maintained | Equal-Weight | $24.00 |
| May 9, 2024 | Barrington Research | Maintained | Outperform | $37.00 |
| Mar 14, 2024 | Stephens & Co. | Maintained | Equal-Weight | $22.00 |
| Mar 14, 2024 | Barrington Research | Maintained | Outperform | $37.00 |
| Jan 3, 2024 | Barrington Research | Maintained | Outperform | $29.00 |
| Nov 3, 2023 | Barrington Research | Maintained | Outperform | $28.00 |
| Aug 14, 2023 | Barrington Research | Upgraded | Market Perform → Outperform | $24.00 |
| Aug 10, 2023 | Stephens & Co. | Maintained | Equal-Weight | $23.00 |

## Frequently Asked Questions

### What is the latest analyst rating on ANIK?

On Sep 18, 2026, B. Riley Securities initiated coverage of Anika Therapeutics at Buy with a price target of $23.00.

## Similar Stocks

- [ANVS](https://www.lighthorse.io/tickers/anvs) — Annovis Bio, Inc. Common Stock

---

Analyst ratings and price targets are the opinions of third-party research firms, not of Light Horse Securities. They are estimates about an uncertain future, are frequently wrong, and are neither a recommendation nor a prediction of actual results.

This page is for informational purposes only. Nothing on it is a recommendation, solicitation or offer to buy or sell any security, nor investment, legal or tax advice. Light Horse Securities Inc does not verify third-party data and is not responsible for its accuracy, completeness or timeliness.

Data provided by [AInvest](https://www.ainvest.com).